Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
Clinical trial NCT04109755 · RECRUITING
Trial details
- NCT number
- NCT04109755
- Sponsor
- University Hospital, Geneva
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2022-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.